Navigation Links
PURE Bioscience and Ciba Strike New Contract for Natural Antimicrobial
Date:12/1/2008

Ciba to Accelerate Global Marketing of Ciba TINOSAN SDC in Personal Care, Household and Industrial Markets

SAN DIEGO and BASEL, Switzerland, Dec. 1 /PRNewswire-FirstCall/ -- PURE Bioscience (Nasdaq: PURE) today announced it has signed a new agreement with Ciba (SWX: CIBN) to market and sell PURE's silver dihydrogen citrate antimicrobial as a preservative and biocide in the personal care, household, and industrial markets worldwide. In the personal care market, PURE granted Ciba exclusive marketing rights for SDC in personal care under trade name Ciba(R) TINOSAN(R) SDC.

(Logo: http://www.newscom.com/cgi-bin/prnh/20060119/LATH060LOGO)

Catherine Ehrenberger, Global Head of Ciba Home & Personal Care Business Line, commented, "With this technology from PURE Bioscience, we are able to support customers in the personal and household care industries as they strive to enhance the antimicrobial effects and shelf life of their formulations. We are especially excited about the opportunities in the cosmetics market, where manufacturers are increasingly expected to deliver antimicrobial benefits without compromising the look and feel of their products."

Michael L. Krall, President and CEO of PURE Bioscience added, "Ciba's global reach, well-established customer base and commitment to innovation make it an excellent partner to drive SDC into the personal care, household and industrial markets."

Krall continued, "Although Ciba's focus is on only one segment of SDC's platform technology potential, these markets are significant and fast growing."

Krall concluded, "As government agencies institute stricter policies on chemical use, corporations face mounting pressure to prot
'/>"/>

SOURCE PURE Bioscience
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
2. Selection of Development Candidate Triggers $0.5 Million Milestone Payment to Ardea Biosciences, Inc.
3. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
4. Ohio Ranks Best in the Midwest for Venture Capital Investment in Health Care Bioscience Industry
5. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
6. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
7. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
8. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
9. Todd R. Nelson Named Chief Executive Officer of eBioscience, Inc.
10. Magellan Biosciences Names Steven E. Diamond, PhD, Chief Scientific Officer
11. Pressure BioSciences, Inc. Issued First Patent in Canada
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... , July 24, 2014  Spherix Incorporated (SPEX) ... fostering and monetization of intellectual property, today announced that ... period ending June 30, 2014 on Monday, August 18, ... at 10 a.m. ET on Monday, August 18, 2014 ... led by the company,s CEO, Anthony Hayes . ...
(Date:7/23/2014)... Emirates (UAE) (PRWEB) July 23, 2014 ... recently announced that its biobanking project, Provia ... Ph.D. to its growing Advisory Board. Scott Wolf ... pleased to have Dr. Vaught onboard with Provia’s ever-expanding ... and expertise that Provia’s management team brings to this ...
(Date:7/23/2014)... July 23, 2014 /PRNewswire-iReach/ -- Think Drinks are a ... the long term. They are the first functional focus ... energy as an alternative to the temporary fix associated ... Indiegogo on July 29, 2014, with hopes to raise ... Photo - http://photos.prnewswire.com/prnh/20140723/129697 ...
(Date:7/23/2014)... , 23 de julio de 2014 /PRNewswire/ ... o la Compañía) ha anunciado hoy una asociación ... (ABIA o el Instituto), para el ... un dispositivo de terapia de señal bioeléctrica (el ... El Instituto, que tiene una importante experiencia ...
Breaking Biology Technology:Spherix Schedules Shareholder Update Call 2Provia Laboratories Adds Dr. Jim Vaught, Ph.D., Former Chief of BBRB, to Advisory Board 2Provia Laboratories Adds Dr. Jim Vaught, Ph.D., Former Chief of BBRB, to Advisory Board 3Provia Laboratories Adds Dr. Jim Vaught, Ph.D., Former Chief of BBRB, to Advisory Board 4truBrain Neuroscientists To Launch More Effective, Healthier Alternative To Energy Drinks On Indiegogo 2ADB International Group Inc. anuncia una asociación con Austen BioInnovation Institute 2ADB International Group Inc. anuncia una asociación con Austen BioInnovation Institute 3ADB International Group Inc. anuncia una asociación con Austen BioInnovation Institute 4ADB International Group Inc. anuncia una asociación con Austen BioInnovation Institute 5ADB International Group Inc. anuncia una asociación con Austen BioInnovation Institute 6
... ... trainer Dr. Rebecca Fitzgerald, known among her medical colleagues as the "Sculptra guru" here in ... physicians at this year,s 4 day SDEF Cosmetic Dermatology Seminar held in Santa Monica, Ca. ... Los Angeles, Ca ...
... , SANTA ANA, Calif. , ... partnership with Prodimed, a company specializing in women,s health, located ... be distributing Prodimed,s extensive line of embryo transfer catheters, oocyte ... , , Prodimed has a ...
... PALO ALTO, Calif., July 21, Varian, Inc. (NasdaqGS: VARI) plans to ... 2009 after 1:00 p.m. Pacific Time (PT) on Wednesday, July 29, 2009. ... review those quarterly results is scheduled to follow at 2:00 p.m. PT ... webcast can be accessed from Varian, Inc.,s Web site at ...
Cached Biology Technology:Looking Older Than You Are May Have Little to Do With Wrinkles 2Looking Older Than You Are May Have Little to Do With Wrinkles 3
(Date:7/23/2014)... drought that has the entire country in its grip is ... also be responsible for the proliferation of a heat-loving amoeba ... and hot springs, which the drought has made warmer than ... of an infection caused by this parasite after swimming in ... nose of an individual and travels to the brain. Nose ...
(Date:7/23/2014)... The Worldwide Innovative Networking in personalized cancer medicine, (the ... Center at Thomas Jefferson University will be ... member of this prestigious group in the Tri-State Area. ... of innovative personalized medicine to the patient by forging ... , "Our participation in the WIN consortium means Jefferson ...
(Date:7/23/2014)... will play an increasingly important role in carbon and ... zones expand, according to research published this week in ... . , University of British Columbia researchers plumbed the ... to chart how microbial community metabolism changes as oxygen ... detailed picture of how SUP05 a bacterial group ...
Breaking Biology News(10 mins):Diseases of another kind 2New partnership brings more personalized cancer treatment to Philadelphia 2Research charts the ecological impact of microbial respiration in the oxygen-starved ocean 2
... This release is available in French . ... of Medicine and the CHUQ Research Center have proven that ... Duchenne muscular dystrophy. The team, led by Professor Jacques P. ... published today in the online version of the scientific journal ...
... Program will feature new study results from the conference ... their presentation at ELCC): Making EGFR ... radiation in patients with locally advanced lung cancer: first ... lung cancer in organ transplant recipients, Hyperfractionated radiotherapy for ...
... PITTSBURGH, April 15 Certain genetic variations may be ... periodontitis, according to two recently published papers by researchers ... and their collaborators. Alexandre R. Vieira, D.D. S., ... professor of oral biology, and his colleagues at the ...
Cached Biology News:Researchers prove the gene responsible for Duchenne muscular dystrophy can be repaired 22nd European Lung Cancer Conference 22nd European Lung Cancer Conference 3Pitt Dental School researchers find susceptibility for caries, gum disease in genes 2
Goat polyclonal to SART3 ( Abpromise for all tested applications). Antigen: Synthetic peptide: MSNADFAKLFLRK, corresponding to C terminal amino acids 951-963 of Human SART3 Entrez Gene ID: 9...
JAB1 Immunogen: Synthetic peptide, conjugated to KLH, corresponding to residues S(201) E Y Q T I P L N K I E D F G V(216) of human JAB1. The sequence is identical in mouse and rat. Storage: -...
Hamartin/TSC1 (1B2) Mouse mAb Ship: Hot Store: -20 C...
Blank Calibration Particles, 3.0-3.4 mu m 5 ml...
Biology Products: